[{"id":"51b8a52a-4e3d-4110-8259-d81a3c2e4a45","acronym":"","url":"https://clinicaltrials.gov/study/NCT05848466","created_at":"2023-05-08T15:03:59.211Z","updated_at":"2024-07-02T16:35:48.780Z","phase":"Phase 1","brief_title":"Assessment of Safety, Tolerability and Pharmacokinetics With BAT8010 for Injection in Advanced Malignant Solid Tumors Patients","source_id_and_acronym":"NCT05848466","lead_sponsor":"Bio-Thera Solutions","biomarkers":" HER-2","pipe":" | ","alterations":" HER-2 expression","tags":["HER-2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e HER-2 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e BAT8010"],"overall_status":"Recruiting","enrollment":" Enrollment 109","initiation":"Initiation: 02/10/2023","start_date":" 02/10/2023","primary_txt":" Primary completion: 05/01/2025","primary_completion_date":" 05/01/2025","study_txt":" Completion: 07/01/2025","study_completion_date":" 07/01/2025","last_update_posted":"2023-05-08"}]